Cerevel Therapeutics Holdings Inc (CERE) is lower by 3.66% Tuesday In Premarket Trading

Cerevel Therapeutics Holdings Inc (CERE) is down -3.66%% today.

CERE has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on CERE!

CERE stock closed at $42.57 and is down -$1.56 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CERE has a roughly average overall score of 66 meaning the stock holds a better value than 66% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. CERE gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Cerevel Therapeutics Holdings Inc currently has the 104th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders. Cerevel Therapeutics Holdings Inc's Overall and Short-Term Technical score paint a mixed picture for CERE's recent trading patterns and forecasted price. Click Here To Get The Full Report on Cerevel Therapeutics Holdings Inc (CERE)